nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrofurantoin—Glucose-6-phosphate dehydrogenase deficiency—Dapsone—leprosy	0.207	0.207	CcSEcCtD
Nitrofurantoin—Lupus-like syndrome—Dapsone—leprosy	0.11	0.11	CcSEcCtD
Nitrofurantoin—Anaemia megaloblastic—Thalidomide—leprosy	0.0565	0.0565	CcSEcCtD
Nitrofurantoin—Polyneuropathy—Thalidomide—leprosy	0.0408	0.0408	CcSEcCtD
Nitrofurantoin—Electrolyte imbalance—Thalidomide—leprosy	0.0318	0.0318	CcSEcCtD
Nitrofurantoin—Liver disorder—Thalidomide—leprosy	0.0195	0.0195	CcSEcCtD
Nitrofurantoin—Cyanosis—Thalidomide—leprosy	0.0188	0.0188	CcSEcCtD
Nitrofurantoin—Interstitial lung disease—Thalidomide—leprosy	0.0188	0.0188	CcSEcCtD
Nitrofurantoin—Nystagmus—Thalidomide—leprosy	0.0186	0.0186	CcSEcCtD
Nitrofurantoin—Psychotic disorder—Dapsone—leprosy	0.0184	0.0184	CcSEcCtD
Nitrofurantoin—Pleural effusion—Thalidomide—leprosy	0.0174	0.0174	CcSEcCtD
Nitrofurantoin—Amblyopia—Thalidomide—leprosy	0.0172	0.0172	CcSEcCtD
Nitrofurantoin—Tingling sensation—Thalidomide—leprosy	0.0165	0.0165	CcSEcCtD
Nitrofurantoin—Numbness—Thalidomide—leprosy	0.016	0.016	CcSEcCtD
Nitrofurantoin—Sensory loss—Thalidomide—leprosy	0.0154	0.0154	CcSEcCtD
Nitrofurantoin—Jaundice cholestatic—Thalidomide—leprosy	0.0151	0.0151	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Dapsone—leprosy	0.0142	0.0142	CcSEcCtD
Nitrofurantoin—Aplastic anaemia—Thalidomide—leprosy	0.0125	0.0125	CcSEcCtD
Nitrofurantoin—Euphoric mood—Thalidomide—leprosy	0.0114	0.0114	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Thalidomide—leprosy	0.0111	0.0111	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Thalidomide—leprosy	0.0102	0.0102	CcSEcCtD
Nitrofurantoin—Vertigo—Dapsone—leprosy	0.0102	0.0102	CcSEcCtD
Nitrofurantoin—Cough—Dapsone—leprosy	0.00991	0.00991	CcSEcCtD
Nitrofurantoin—Psychotic disorder—Thalidomide—leprosy	0.00943	0.00943	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Thalidomide—leprosy	0.0087	0.0087	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Thalidomide—leprosy	0.00852	0.00852	CcSEcCtD
Nitrofurantoin—Eosinophilia—Thalidomide—leprosy	0.00826	0.00826	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Dapsone—leprosy	0.00758	0.00758	CcSEcCtD
Nitrofurantoin—Drowsiness—Thalidomide—leprosy	0.00744	0.00744	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00738	0.00738	CcSEcCtD
Nitrofurantoin—Body temperature increased—Dapsone—leprosy	0.00733	0.00733	CcSEcCtD
Nitrofurantoin—Abdominal pain—Dapsone—leprosy	0.00733	0.00733	CcSEcCtD
Nitrofurantoin—Renal failure—Thalidomide—leprosy	0.00731	0.00731	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Thalidomide—leprosy	0.00729	0.00729	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Thalidomide—leprosy	0.00694	0.00694	CcSEcCtD
Nitrofurantoin—Hepatitis—Thalidomide—leprosy	0.00668	0.00668	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Thalidomide—leprosy	0.00665	0.00665	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Thalidomide—leprosy	0.00632	0.00632	CcSEcCtD
Nitrofurantoin—Chills—Thalidomide—leprosy	0.00599	0.00599	CcSEcCtD
Nitrofurantoin—Alopecia—Thalidomide—leprosy	0.0059	0.0059	CcSEcCtD
Nitrofurantoin—Vomiting—Dapsone—leprosy	0.00589	0.00589	CcSEcCtD
Nitrofurantoin—Headache—Dapsone—leprosy	0.00581	0.00581	CcSEcCtD
Nitrofurantoin—Flatulence—Thalidomide—leprosy	0.00573	0.00573	CcSEcCtD
Nitrofurantoin—Nausea—Dapsone—leprosy	0.00551	0.00551	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Thalidomide—leprosy	0.0054	0.0054	CcSEcCtD
Nitrofurantoin—Anaemia—Thalidomide—leprosy	0.00537	0.00537	CcSEcCtD
Nitrofurantoin—Malaise—Thalidomide—leprosy	0.00524	0.00524	CcSEcCtD
Nitrofurantoin—Vertigo—Thalidomide—leprosy	0.00522	0.00522	CcSEcCtD
Nitrofurantoin—Leukopenia—Thalidomide—leprosy	0.00521	0.00521	CcSEcCtD
Nitrofurantoin—Cough—Thalidomide—leprosy	0.00507	0.00507	CcSEcCtD
Nitrofurantoin—Chest pain—Thalidomide—leprosy	0.00495	0.00495	CcSEcCtD
Nitrofurantoin—Myalgia—Thalidomide—leprosy	0.00495	0.00495	CcSEcCtD
Nitrofurantoin—Discomfort—Thalidomide—leprosy	0.00489	0.00489	CcSEcCtD
Nitrofurantoin—Confusional state—Thalidomide—leprosy	0.00479	0.00479	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Thalidomide—leprosy	0.00465	0.00465	CcSEcCtD
Nitrofurantoin—Anorexia—Thalidomide—leprosy	0.00452	0.00452	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Thalidomide—leprosy	0.00432	0.00432	CcSEcCtD
Nitrofurantoin—Paraesthesia—Thalidomide—leprosy	0.00426	0.00426	CcSEcCtD
Nitrofurantoin—Dyspnoea—Thalidomide—leprosy	0.00423	0.00423	CcSEcCtD
Nitrofurantoin—Somnolence—Thalidomide—leprosy	0.00422	0.00422	CcSEcCtD
Nitrofurantoin—Dyspepsia—Thalidomide—leprosy	0.00418	0.00418	CcSEcCtD
Nitrofurantoin—Decreased appetite—Thalidomide—leprosy	0.00413	0.00413	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Thalidomide—leprosy	0.0041	0.0041	CcSEcCtD
Nitrofurantoin—Constipation—Thalidomide—leprosy	0.00406	0.00406	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Thalidomide—leprosy	0.00391	0.00391	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Thalidomide—leprosy	0.00388	0.00388	CcSEcCtD
Nitrofurantoin—Abdominal pain—Thalidomide—leprosy	0.00375	0.00375	CcSEcCtD
Nitrofurantoin—Body temperature increased—Thalidomide—leprosy	0.00375	0.00375	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Thalidomide—leprosy	0.0035	0.0035	CcSEcCtD
Nitrofurantoin—Asthenia—Thalidomide—leprosy	0.00341	0.00341	CcSEcCtD
Nitrofurantoin—Diarrhoea—Thalidomide—leprosy	0.00325	0.00325	CcSEcCtD
Nitrofurantoin—Dizziness—Thalidomide—leprosy	0.00314	0.00314	CcSEcCtD
Nitrofurantoin—Vomiting—Thalidomide—leprosy	0.00302	0.00302	CcSEcCtD
Nitrofurantoin—Rash—Thalidomide—leprosy	0.00299	0.00299	CcSEcCtD
Nitrofurantoin—Headache—Thalidomide—leprosy	0.00297	0.00297	CcSEcCtD
Nitrofurantoin—Nausea—Thalidomide—leprosy	0.00282	0.00282	CcSEcCtD
